| ERIS Lifesciences Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 540596 |
NSE Symbol : ERIS |
P/E(TTM) : 93.14 |
|
ISIN Demat : INE406M01024 |
Div & Yield% : - |
EPS(TTM) : 15.14 |
|
Book Value(₹) : 185.48 |
Market Cap(₹Cr) : 19,189.53 |
Face Value(₹) : 1.00 |
| Particulars | Mar '24 | Mar '23 | Mar '22 | Mar '21 | Mar '20 |
|---|---|---|---|---|---|
| INCOME : | |||||
| Sales Turnover | 1,528.28 | 1,340.37 | 1,215.73 | 1,108.83 | 1,020.23 |
| Excise Duty | - | - | - | - | - |
| Net Sales | 1,528.28 | 1,340.37 | 1,215.73 | 1,108.83 | 1,020.23 |
| Other Income | 34.83 | 17.26 | 28.99 | 10.00 | 14.73 |
| Stock Adjustments | 13.15 | -8.50 | -2.49 | 12.57 | -17.47 |
| Total Income | 1,576.26 | 1,349.13 | 1,242.23 | 1,131.40 | 1,017.49 |
| EXPENDITURE : | |||||
| Raw Materials | 293.31 | 227.88 | 197.16 | 211.08 | 146.88 |
| Power and Fuel Cost | 4.46 | 4.41 | 4.01 | 3.89 | 4.54 |
| Other Manufacturing Expenses | 16.80 | 11.50 | 7.47 | 7.16 | 10.62 |
| Selling and Administration Expenses | 319.25 | 242.67 | 215.51 | 181.66 | 219.34 |
| Miscellaneous Expenses | 122.13 | 87.78 | 84.93 | 93.13 | 73.93 |
| Employee Benefit Expenses | 331.67 | 252.52 | 220.11 | 207.02 | 191.73 |
| Less: Preoperative Expenditure | - | - | - | - | - |
| Total Expenses | - | - | - | - | - |
| Operating Profit | 488.64 | 522.38 | 513.04 | 427.47 | 370.44 |
| Interest | 57.42 | 20.81 | 3.05 | 0.94 | 1.97 |
| Gross Profit | 431.22 | 501.57 | 509.99 | 426.53 | 368.47 |
| Depreciation | 102.39 | 64.66 | 51.46 | 37.64 | 44.88 |
| Profit Before Tax | 328.83 | 436.91 | 458.53 | 388.89 | 323.59 |
| Current Tax | 57.64 | 76.50 | 80.17 | 70.18 | 57.49 |
| Fringe Benefit tax | - | - | - | - | - |
| Deferred Tax | -28.52 | -37.59 | -38.83 | -31.90 | -25.17 |
| Reported Net Profit | 299.71 | 398.01 | 417.19 | 350.61 | 291.27 |
| Extraordinary Items | 2.79 | 5.17 | -1.72 | 2.33 | 4.49 |
| Adjusted Net Profit | 296.92 | 392.84 | 418.91 | 348.28 | 286.78 |
| Adjustment below Net Profit | -2.76 | -0.15 | -1.01 | -1.28 | -100.21 |
| Profit/Loss Balance carried down | 2,190.21 | 1,892.28 | 1,557.74 | 1,283.09 | 1,139.01 |
| Statutory Appropriations | - | - | - | - | - |
| Appropriations | - | 99.93 | 81.65 | 74.68 | 46.98 |
| P & L Balance carried down | 2,487.16 | 2,190.21 | 1,892.28 | 1,557.74 | 1,283.09 |
| Dividend | - | 99.93 | 81.65 | 74.68 | 38.97 |
| Preference Dividend | - | - | - | - | - |
| Equity Dividend (%) | - | 735.00 | 601.00 | 550.00 | 287.00 |
| Dividend Per Share(Rs) | - | 7.35 | 6.01 | 5.50 | 2.87 |
| Earnings Per Share-Unit Curr | 22.03 | 29.27 | 30.69 | 25.82 | 21.45 |
| Earnings Per Share(Adj)-Unit Curr | 22.03 | 29.27 | 30.69 | 25.82 | 21.45 |
| Book Value | 185.55 | 163.39 | 141.11 | 116.03 | 95.72 |
| Book Value(Adj)-Unit Curr | 185.55 | 163.39 | 141.11 | 116.03 | 95.72 |